An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.

Slides:



Advertisements
Similar presentations
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Advertisements

Health in Prisons Project Establishing a Monitoring Mechanism on Prison Health Indicators and Health Determinants Working Party on Information on Lifestyle.
REPORT Full report Executive summary Methodology STATISTICAL ANNEX Seizures Drug use Prices Illicit laboratories.
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
Making Alberta Communities Safer The Challenges of Sustainability Crystal Hincks Impact & Evaluation Research Services Prof. John Winterdyk Dept. of Justice.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Problem drug use, HIV and injecting: an overview of the European experience Paul Griffiths, EMCDDA Drug Control in the Baltic Region, Vilnius, 27 September.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.
M IGRATION IN L ITHUANIA DEBATE ANSWERING THE CHALLENGES OF MIGRATION AND MULTICULTURALISM.
Advanced Briefing to Member States
A Health Based Approach Within The UN Conventions: Examples Of Practice Fay Watson, Vice Chair: EU Civil Society Forum on Drugs.
Major findings from the 2013 World Drug Report. Drug use Overall drug use, including problem drug use, has remained largely stable over the past 5 years.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Sofia City of Oslo Agency for Alcohol and Drug Addiction Services/Competence Centre Agency for Alcohol and Drug Addiction Services, Competence.
NACD and NDST 8 th March 2007 A Joint Report by the National Drugs Strategy Team (NDST) and the National Advisory Committee on Drugs (NACD)
HIV and drug prevention in Estonia Harm reduction services
Treatment of drug addiction in prisons
Estimation of the Prevalence of Problem Drug Use in Lithuania Dr Gordon Hay Centre for Drug Misuse Research University of Glasgow, United Kingdom.
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
Harm Reduction.
Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Annual report 2010: the state of the drugs problem in Europe.
Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
Annual report 2009: the state of the drugs problem in Europe NB Embargo 5 November :00 CET (Brussels time)
Alcohol policy in Catalonia Joan Colom Antoni Gual Lidia Segura March 2007, Pécs, Baranya (H)
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
Australia’s Drug Policy Greg Denham Nossal Institute for Global Health.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
What can we learn from the Portuguese decriminalization of illicit drugs? Dr Caitlin Hughes Drug Policy Modelling Program NDARC, The University of New.
Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
Delivery Systems for Substance Abuse Treatment: Integration with Primary Care and Mental Health and Social Services (Also referred to as) Delivery Systems.
EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,
04/06/2016Presentation name104/06/2016Presentation name1 Adult Drug Misuse Kerry Anderson – Modernisation Manager, Public Health.
Module 1 General introduction to substitution treatment.
Eurocare recommendations for a future EU alcohol strategy June 2012.
Gregor Burkhart - EMCDDA / OEDT - 1 … how to deal with Risks - drugs - Gregor Burkhart, EMCDDA, July 2009 CONFERENCE ON THE HEALTH OF YOUNG PEOPLE: BE.
Harm Reduction International
Epidemiology of addictive disorders: a brief review MRCPsych addiction psychiatry seminar series Dr Stuart McLaren 2 nd March 2012.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
WOMEN PROFILE AND GENDER ANALYSIS IN TREATMENT DATA UNODC DATA.
Delivery Systems for Substance Abuse Treatment Country Presentation - Slovakia Lubomir Okruhlica, M.D., Ph.D. Institute on Drug Dependencies, CTDD Bratislava.
Annual report 2012: the state of the drugs problem in Europe Name, date.
PREVENTION OF DRUG ABUSE AMONG VULNERABLE GROUPS Dr Marcus Roberts Director of Policy and Membership DRUGSCOPE.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.
Briefing to Member States Information under embargo
Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.
Young people, substance misuse and PHE
6% of adults had used one or more illicit drugs in last 12 months.
Drug addiction: Therapeutic problems in everyday clinical practice
WHO minimum public health data set on prison health
Cannabis epidemic or return of opoid problems or decrease of high risk drug use among young adults in Austria Addictions Lisbon 2017, Paper Session 2 –
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
World Drug Report 2018.
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Comparison of data from WBE with other sources
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
German Drug and Addiction Policy
Skopje, 21 November 2017, General Population Survey results– launch
Presentation transcript:

An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna

2 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Community Agency Established: 1993 Staff: 102 The drug information hub in Europe Market Drug use Consequences Interventions Standards Prison Internet Licit substances

3 Participating Countries: 27 EU Member States, Croatia, Turkey and Norway Market Drug use Consequences Interventions Standards Prison Internet Licit substances

4 Trends Market Drug use Consequences Interventions Developments Standards and quality of interventions Drugs in prison Drugs and the internet Drugs and licit psychotropic substances Data: Annual Report more recent details

5 Herbal: seizures (250% of 2003) 90 tons: Turkey 31t, Germany 9t Resin seizures (increased) 900 t (increased last years) More than half of seizures/amount: Spain Proper balance? Cannabis Market Drug use Consequences Interventions Standards Prison Internet Licit substances

6 Number of seizures increasing for last 20 years: Quantities seized decreased since 2006: 67 tonnes New smuggling techniques Cocaine seizures Market Drug use Consequences Interventions Standards Prison Internet Licit substances

7 Heroin seizures and quantities seized Market Drug use Consequences Interventions Standards Prison Internet Licit substances

8 New Drugs – “Legal Highs” New groups & large number of new unregulated compounds Marketed in various combinations or as products laced with synthetic compounds Difficulties in analytical identification Little or no knowledge of pharmacology, toxicity, safety profile Increasing interaction between the “legal-highs” market & organised crime Market Drug use Consequences Interventions Standards Prison Internet Licit substances

million Europeans have ever used cannabis (22.5 %) 23 million in the past year (6.8 %) 17 million are between 15 and 34 years old Trends mostly downwards (not Easter Europe) Cannabis Market Drug use Consequences Interventions Standards Prison Internet

10 Cannabis use: last year prevalence among young adults Market Drug use Consequences Interventions Standards Prison Internet Licit substances

11 14 million Europeans have ever used cocaine (4.1 %) 4 million during the past year (1.3 %) 3 million are between 15 and 34 years old Cocaine Market Drug use Consequences Interventions Standards Prison Internet Licit substances

12 Cocaine use: last year prevalence among young adults in Europe, Australia, Canada and the USA Market Drug use Consequences Interventions Standards Prison Internet Licit substances

13 Cocaine use: last year prevalence among young adults Market Drug use Consequences Interventions Standards Prison Internet Licit substances

million young adults (1.7 %) have used ecstasy in the last year 1.5 million young adults (1.2 %) have used amphetamines in the last year Ecstasy and amphetamines Market Drug use Consequences Interventions Standards Prison Internet Licit substances

15 About 1.35 million (EU & Norway): or 0.4 % of the adult population ( %) Injectors estimates around half of this or less and appear to be still decreasing Opioids Market Drug use Consequences Interventions Standards Prison Internet Licit substances

to one million in the EU and Norway — 0.26 % of the adult population Decrease in the proportion of injectors among opioid users entering treatment Injecting drug users Market Drug use Consequences Interventions Standards Prison Internet Licit substances

17 Reports of problem opioid use in Russia and Ukraine (UNODC): 2−4 times the EU average High proportion of drug injectors and levels of HIV infections Problem opioid use in neighbouring countries Market Drug use Consequences Interventions Standards Prison Internet Licit substances

18 Trends in newly reported HIV infections in injecting drug users in four EU Member States reporting high rates of infection Market Drug use Consequences Interventions Standards Prison Internet Licit substances

19 Drug-induced deaths: change 2004 to 2007/8 Market Drug use Consequences Interventions Standards Prison Internet Licit substances

20 Around cocaine-related deaths were reported in 2008 Marked increases in Spain and the United Kingdom Cocaine deaths Market Drug use Consequences Interventions Standards Prison Internet Licit substances

21 Prevention Environmental strategies: School policies Universal prevention: Normative beliefs, social competence, parenting Selective prevention: Socially excluded groups, vulnerable families Indicated prevention Early childhood problems etc. Market Drug use Consequences Interventions Standards Prison Internet Licit substances

22 Prevention: Provision of selective prevention Market Drug use Consequences Interventions Standards Prison Internet Licit substances

23 Large investments in treatment At least 1 million Europeans undergo drug treatment every year Major increase over the last decades: new providers and new needs Market Drug use Consequences Interventions Standards Prison Internet Licit substances

24 Year or introduction of methadone maintenance treatment (MMT) and high dosage buprenorphine treatment (HDBT) in Europe

25 Large investments in treatment: opioid substitution treatment Market Drug use Consequences Interventions Standards Prison Internet Licit substances

26 Estimated proportion of problem opioid users in substitution treatment Market Drug use Consequences Interventions Standards Prison Internet Licit substances

27 Trends in treatment entries by primary drug Market Drug use Consequences Interventions Standards Prison Internet Licit substances

28 Treatment entries by primary drug: New clients Market Drug use Consequences Interventions Standards Prison Internet Licit substances

29 Older drug users in drug treatment Treatment starters above year before: usually below 10% Today: 19% Portugal: 28% Market Drug use Consequences Interventions Standards Prison Internet Licit substances

30 Older drug users in drug treatment Mainly heroin addicts Infectious diseases, mental health problems, living conditions more difficult Premature aging Needed: special services/facilities or closer collaboration between general health care and drug care Market Drug use Consequences Interventions Standards Prison Internet Licit substances

31 Reintegration 47% outpatient clients unemployed 40 % clients entering treatment: no secondary education paid employment important part in reintegration into society and long term treatment outcome -----> Focus on employability Market Drug use Consequences Interventions Standards Prison Internet Licit substances

32 Guidelines in Europe Market Drug use Consequences Interventions Standards Prison Internet Licit substances

33 Guidelines in Europe Market Drug use Consequences Interventions Standards Prison Internet Licit substances

34 Market Drug use Consequences Interventions Standards Prison Internet Licit substances

35 Foto portale linee guida Market Drug use Consequences Interventions Standards Prison Internet Licit substances

36 Situation people in penal institutions in the EU EU: 120/ , Russia: 629/ , US: 756/ Reports of 10−30 % incarcerated because of drug law offences Drug use prevalence much higher than among the general population Increased overdose risk after prison release Market Drug use Consequences Interventions Standards Prison Internet Licit substances

37 Situation Drug use prevalence much higher than among the general population Entitlement to equivalent services as in the community Risk reduction Allows to reach highly problematic group Possible effect on public health Market Drug use Consequences Interventions Standards Prison Internet Licit substances

38 Treatment in prison Some countries recognise the need to develop specific strategies and interventions Transfer of prison health to Ministries of Health; integration of drugs or health services in prison Development of specific standards Market Drug use Consequences Interventions Standards Prison Internet Licit substances

39 Internet – an additional risk 170 online shops Substances sold as ‘legal highs’ Rapid adaptation to control measures Market Drug use Consequences Interventions Standards Prison Internet Licit substances

40 Internet – an additional resource Information provision: warnings Contacts to drug users (Cannabis, cocaine) Internet based treatment Mixed approaches Market Drug use Consequences Interventions Standards Prison Internet Licit substances

41 Drugs and licit substances Prevention: broader than drugs Tobacco ban and cannabis regulations Drugs policy vs. alcohol policy vs. policy on psychotropic substances Market Drug use Consequences Interventions Standards Prison Internet Licit substanc

42 Drugs and licit substances Overlapping target groups: multiple problems, substances, gambling, social conduct Overlapping substances: “legal highs”, pharmaceutics Overlapping objectives: limit access, reduce risks, avoid secondary problems, treat addictions … Market Drug use Consequences Interventions Standards Prison Internet Licit substanc

43 Conclusions Overall stable, partly decreasing Concern: Cocaine, synthetic drugs, “legal highs” Local hot spots: Crack cocaine, alcohol/cannabis, young opiate users Interventions well developed, increased quality Challenges: new substances, new needs Opportunities: new media, programmes,treatments Policy sets objectives Carefull implementation needed EMCDDA: monitoring and quality development Market Drug use Consequences Interventions Standards Prison Internet

44 Thanks for your attention More information under: emcdda.europa.eu